Print This Page

Home Agriculture & Food Sap & Extract Herbal Extract

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine pictures & photos

Manufacture Macleaya Cordata Extract Sanguinarine

Certification:	ISO, FDA, HACCP, Kosher, Halal
Assay Method:	HPLC
Application Form:	Injection, Lotion, Suppository, Paste, Tablet, Capsule
Application:	Medicine, Animal Feed Additive
State:	Powder
Extract Source:	Macleaya Cordata

Samples:	US$ 1/Piece 1 Piece(Min.Order) \| Request Sample

Customization:	Available \| Customized Request

Contact Supplier

Contact Now

Inquiry Basket

Kingherbs Limited

360° Virtual Tour

Diamond Member Since 2007

Suppliers with verified business licenses

Audited Supplier

Trading Company

Product Description

Company Info.

Basic Info.

Model NO.

2447-54-3

Product Name

Macleaya Cordata Extract

Botanical Source

Macleaya Cordata (Willd.) R. Br.

Active Ingredient

Sanguinarine

Appearance

Fine Orange Red Powder

Solubility

Soluble in Water

Molecular Fomular

C20h14no4

Molecular Weight

332.09

Transport Package

Packed in Fiber Drum, LDPE Bag Inside.

Specification

Sanguinarine0.2%-40%

Trademark

Kingherbs

Origin

China

HS Code

2938909090

Production Capacity

5000kgs/Month

Product Description

Macleaya Cordata Extract

Active ingredients: Sanguinarine
Molecular Fomular: C20H14NO4
Molecular Weight: 332.09

Introduction of Sanguinarine
Sanguinarine is a toxin that kills animal cells through its action on the Na+-K+-ATPase transmembrane protein. Epidemic dropsy is a disease that results from ingesting sanguinarine.
If applied to the skin, sanguinarine kills cells and may destroy tissue. In turn, the bleeding wound may produce a massive scab, called an eschar. For this reason, sanguinarine is termed anescharotic.
Preliminary pre-clinical in vitro and in vivo studies have demonstrated that sanguinarine causes apoptosis in human cancer cells, and recommend study of sanguinarine as a potential cancer treatment.A study conducted by the Case Western Reserve University in 2000 found that low doses of sanguinarine caused this apoptosis in cancerous human epidermoid carcinoma cells while little reaction from normal human skin cells was observed. However, no products containing sanguinarine are currently approved by the FDA for the treatment of cancer; the FDA warns that unapproved bloodroot preparations are ineffective and dangerous.

Sanguinarine Suppresses Prostate Tumor Growth and Inhibits Survivin Expression
Prostate cancer is a frequently occurring disease and is the second leading cause of cancer-related deaths of men in the United States. Current treatments have proved inadequate in curing or controlling prostate cancer, and a search for agents for the management of this disease is urgently needed. Survivin plays an important role in both progression of castration-resistant prostate cancer and resistance to chemotherapy. Altered expression of survivin in prostate cancer cells is associated with cancer progression, drug/radiation resistance, poor prognosis, and short patient survival. In the present study, the authors performed a cell-based rapid screen of the Prestwick Chemical Library consisting of 1120 Food and Drug Administration-approved compounds with known safety and bioavailability in humans to identify potential inhibitors of survivin and anticancer agents for prostate cancer. Sanguinarine, a benzophenanthridine alkaloid derived primarily from the bloodroot plant, was identified as a novel inhibitor of survivin that selectively kills prostate cancer cells over "normal" prostate epithelial cells. The authors found that sanguinarine inhibits survivin protein expression through protein degradation via the ubiquitin-proteasome system. Sanguinarine induces apoptosis and inhibits growth of human prostate cancer cells and in vivotumor formation. Administration of sanguinarine, beginning 3 days after ectopic implantation of DU145 human prostate cancer cells, reduces both tumor weight and volume. In addition, sanguinarine sensitized paclitaxel-mediated growth inhibition and apoptosis, offering a potential therapeutic strategy for overcoming taxol resistance. These results suggest that sanguinarine may be developed as an agent either alone or in combination with taxol for treatment of prostate cancer overexpressing survivin.
Manufacture Macleaya Cordata Extract Sanguinarine

Manufacture Macleaya Cordata Extract Sanguinarine

Manufacture Macleaya Cordata Extract Sanguinarine

Manufacture Macleaya Cordata Extract Sanguinarine

Manufacture Macleaya Cordata Extract Sanguinarine

Send your message to this supplier

*From:

*To:

*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for?  Post a Sourcing Request Now

Find Similar Products By Category

Supplier Homepage Products Plant Extract Others Plant Extract Manufacture Macleaya Cordata Extract Sanguinarine

Hot Searches

Macleaya Cordata Extract bulkbuy

You Might Also Like

Product Groups

More Product Catalogs

Contact Supplier

Contact Now

Inquiry Basket

Kingherbs Limited

360° Virtual Tour

Diamond Member Since 2007

Suppliers with verified business licenses

Audited Supplier

Trading Company

Number of Employees

15

Year of Establishment

2011-08-31